04:23 PM EDT, 09/17/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on September 17, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $414,401. Following the Form 4 filing with the SEC, Malik has control over a total of 120,920 shares of the company, with 120,920 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224024083/xslF345X05/form4.xml